Evidence map›Paper›PMID 29104777›Full record

ArticleActa naturae

Studying the Specific Activity of the Amide Form of HLDF-6 Peptide using the Transgenic Model of Alzheimer's Disease.

A P Bogachouk, Z I Storozheva, G B Telegin, A S Chernov, A T Proshin, V V Sherstnev, Yu A Zolotarev, V M Lipkin

Open access · bronzeAbstract read
PubMed Full text at PMC
In one paragraph

Article in Acta naturae. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

A P BogachoukShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya Str., 16/10, Moscow, 117997, Russia.
Z I StorozhevaV. Serbsky Federal Medical Research Center of Psychiatry and Narcology, Ministry of Health, Kropotkinskiy Lane, 23, Moscow, 119034, Russia.
G B TeleginBranch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Nauki Ave., 6, Moscow oblast, 142290, Russia.
A S ChernovBranch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Nauki Ave., 6, Moscow oblast, 142290, Russia.
A T ProshinAnokhin Institute of Normal Physiology, Russian Academy of Sciences, Baltiyskaya Str., 8, Moscow, 125315, Russia.
V V SherstnevAnokhin Institute of Normal Physiology, Russian Academy of Sciences, Baltiyskaya Str., 8, Moscow, 125315, Russia.
Yu A ZolotarevInstitute of Molecular Genetics, Russian Academy of Sciences, Kurchatov Sq., 2, Moscow, 123182 , Russia.
V M LipkinShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya Str., 16/10, Moscow, 117997, Russia.
Institute of Bioorganic Chemistry · RURussian Academy of Sciences · RUInstitute of Molecular Genetics · RUMinistero della Salute · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neuroprotective and nootropic activities of the amide form (AF) of the HLDF-6 peptide (TGENHR-NH

Indexed as

Alzheimer’s diseaseamide form of HLDF-6 peptideDifferentiation factor HLDFneuroprotective and nootropic activitiestransgenic mice

Identifiers

PMID29104777
PMCPMC5662275
OpenAlexW2774663711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.